Seoul
South Korea
3
2016-06-09
3
2019-01-22
These are the the leading inventors for applications assigned to ABLBIO:
ABLBIO based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Dual-targeting protein binding specifically to DLL4 and VEGF and use thereof
#2 | 2016-05-19 ✅ Patent 10,071,170 granted on 2018-09-11Antibody-drug conjugate having improved stability and use thereof
#3 | 2015-07-02 ✅ Patent 9,598,483 granted on 2017-03-21Monoclonal antibody binding specifically to DLL4 and use thereof
Also check out ABLBIO's (Seoul, South Korea) applicant profile with 3 patent applications submitted.
520192 ⎘